Region’s Reputation for Cell & Gene Therapy Grew in 2020
The Greater Philadelphia region’s reputation as a center for the cell and gene therapy industry grew in 2020 as breakthrough research from industry academia pioneers is increasingly complemented by strong capital investment and real estate projects meeting the specialized land, building, and lab development needs of start-up, scaling and relocating companies.
Investment
According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment deals in 2020, valued at more than $12 billion, including six in the cell and gene therapy space totaling $4.5 billion. Among the cell and gene therapy investment […]